English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52715662    線上人數 :  561
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"hsu c h"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 796-820 / 1656 (共67頁)
<< < 27 28 29 30 31 32 33 34 35 36 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2020-05-25T07:35:33Z Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens Chia-Chi Lin; Hsu C.-H; Huang C.-Y; Tsai Y.-C; Huang K.-H; Cheng A.-L; Pu Y.-S.
臺大學術典藏 2020-05-25T07:35:33Z Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma Chia-Chi Lin; Hsu C.-H; Huang C.-Y; Cheng A.-L; Vogelzang N.J; Pu Y.-S.
臺大學術典藏 2020-05-25T07:35:32Z Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment Yang C.-H.;Yang P.-C;Cheng A.-L;Chia-Chi Lin;Hsu C.-H;Yu C.-J;Chang Y.-C;Hsu C;Lin Z.-Z; Lin Z.-Z; Hsu C; Chang Y.-C; Yu C.-J; Hsu C.-H; Chia-Chi Lin; Cheng A.-L; Yang P.-C; Yang C.-H.
臺大學術典藏 2020-05-25T07:35:32Z Systemic therapy for metastatic urothelial carcinoma Chia-Chi Lin; Hsu C.-H; Pu Y.-S; Vogelzang N.J.
臺大學術典藏 2020-05-25T07:35:32Z Weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in hormone-refractory prostate cancer: In vitro combined effects and a Phase II trial Chia-Chi Lin; Hsu C.-H; Hour T.-C; Cheng A.-L; Huang C.-Y; Huang K.-H; Chen J; Pu Y.-S.
臺大學術典藏 2020-05-25T07:35:32Z Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma Hsu C.-H.;Cheng A.-L;Hsu W.-L;Tsai Y.-C;Hsu C;Yang C.-H;Yeh K.-H;Chia-Chi Lin; Chia-Chi Lin; Yeh K.-H; Yang C.-H; Hsu C; Tsai Y.-C; Hsu W.-L; Cheng A.-L; Hsu C.-H.
臺大學術典藏 2020-05-25T07:35:31Z Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: Results of a retrospective non-randomized study Cheng J.C.-H.;Lee Y.-C;Tsai Y.-C;Hsu C.-H;Chang Y.-L;Lee J.-M;Chia-Chi Lin;Hsu F.-M; Hsu F.-M; Chia-Chi Lin; Lee J.-M; Chang Y.-L; Hsu C.-H; Tsai Y.-C; Lee Y.-C; Cheng J.C.-H.
臺大學術典藏 2020-05-25T07:35:30Z Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinoma Chia-Chi Lin; Pu Y.-S; Hsu C.-H; Keng H.-Y; Cheng A.-L; Yang C.-H.
臺大學術典藏 2020-05-25T07:35:29Z Association of clinical and dosimetric factors with postoperative pulmonary complications in esophageal cancer patients receiving intensity-modulated radiation therapy and concurrent chemotherapy followed by thoracic esophagectomy Hsu F.-M; Lee Y.-C; Lee J.-M; Hsu C.-H; Chia-Chi Lin; Tsai Y.-C; Wu J.-K; Cheng J.C.-H.
臺大學術典藏 2020-05-25T07:35:29Z Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer Huang C.-Y; Cheng J.C; Chia-Chi Lin; Hsu C.-H; Tsai Y.-C; Hsu F.-M; Huang K.-H; Cheng A.-L; Pu Y.-S.
臺大學術典藏 2020-05-25T07:35:27Z Polymorphism in epidermal growth factor receptor intron 1 predicts prognosis of patients with esophageal cancer after chemoradiation and surgery Lee J.-M; Yang S.-Y; Yang P.-W; Shun C.-T; Wu M.-T; Hsu C.-H; Chia-Chi Lin; Cheng J.-C.-H; Wang Y.-H; Chuang T.-H; Chen J.-S; Hsu H.-H; Huang P.-M; Kuo S.-W; Lee Y.-C.
臺大學術典藏 2020-05-25T07:35:27Z Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma Tsai Y.-C; Hsu C.-H; Chia-Chi Lin; Hsu F.-M; Lee J.-M; Huang P.-M; Lee Y.-C; Chia-Hsien Cheng J.
臺大學術典藏 2020-05-25T07:35:24Z Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapy Chen W.-W; Chia-Chi Lin; Huang T.-C; Cheng A.-L; Yeh K.-H; Hsu C.-H.
臺大學術典藏 2020-05-25T07:35:22Z A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies Chia-Chi Lin; Su W.-C; Yen C.-J; Hsu C.-H; Su W.-P; Yeh K.-H; Lu Y.-S; Cheng A.-L; Huang D.C.-L; Fritsch H; Voss F; Taube T; Yang J.C.-H.
臺大學術典藏 2020-05-25T07:35:20Z Systematic review and network meta-analysis: Neoadjuvant chemoradiotherapy for locoregional esophageal cancer Huang T.-C; Hsu C.-H; Chia-Chi Lin; Tu Y.-K.
臺大學術典藏 2020-05-25T07:35:20Z Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma Guo J.-C; Huang T.-C; Chia-Chi Lin; Hsieh M.-S; Chang C.-H; Huang P.-M; Lee J.-M; Hsu F.-M; Cheng J.C.-H; Wang H.-P; Yeh K.-H; Cheng A.-L; Hsu C.-H.
臺大學術典藏 2020-05-25T07:35:15Z A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement Chiang Y; Cheng J.C.-H; Huang C.-Y; Tsai Y.-C; Chia-Chi Lin; Hsu C.-H; Cheng A.-L; Pu Y.-S.
臺大學術典藏 2020-05-25T07:35:12Z Response to Nivolumab as Salvage Therapy in a Patient with Thymic Carcinoma Yang P.-C; Guo J.-C; Hsieh M.-S; Chia-Chi Lin; Hsu C.-H.
臺大學術典藏 2020-05-25T07:35:12Z Do We Need to Add Postoperative Radiotherapy in Patients Undergoing Trimodality Therapy for Esophageal Squamous Cell Carcinoma with Positive Lymph Nodes Disease? Huang P.-M; Hsu F.-M; Chia-Chi Lin; Hsu C.-H; Cheng J.C.-H; Lee J.-M.
臺大學術典藏 2020-05-25T07:35:12Z Number of resected lymph nodes and survival of patients with locally advanced esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy Guo J.-C; Chia-Chi Lin; Huang T.-C; Huang P.-M; Kuo H.-Y; Chang C.-H; Wang C.-C; Cheng J.C.-H; Yeh K.-H; Hsu C.-H; Lee J.-M.
臺大學術典藏 2020-05-25T07:35:05Z Improved prognosis with induction chemotherapy in pathological complete responders after trimodality treatment for esophageal squamous cell carcinoma: Hypothesis generating for adjuvant treatment Cheng J.C.-H.;Hsieh M.-S;Chang Y.-L;Chia-Chi Lin;Hsu C.-H;Huang P.-M;Lee J.-M;Tsai C.-L;Hsu F.-M;Lu S.-L; Lu S.-L; Hsu F.-M; Tsai C.-L; Lee J.-M; Huang P.-M; Hsu C.-H; Chia-Chi Lin; Chang Y.-L; Hsieh M.-S; Cheng J.C.-H.
臺大學術典藏 2020-05-25T07:35:05Z Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma Huang T.-C; Chia-Chi Lin; Wu Y.-C; Chia-Hsien Cheng J; Lee J.-M; Wang H.-P; Huang P.-M; Hsu F.-M; Yeh K.-H; Cheng A.-L; Tzen K.-Y; Hsu C.-H.; Hsu C.-H.;Tzen K.-Y;Cheng A.-L;Yeh K.-H;Hsu F.-M;Huang P.-M;Wang H.-P;Lee J.-M;Chia-Hsien Cheng J;Wu Y.-C;Chia-Chi Lin;Huang T.-C
臺大學術典藏 2020-05-25T07:35:01Z A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors Chia-Chi Lin;Tajima N;Oguma T;Ishizuka T;Sugihara M;Chiu L.Y;Sasaki S.-I;Cheng A.-L;Yang J.C.-H;Yen Y.-H;Hsu C.-H;Chen T.W.-W;Lee J.-H; Lee J.-H; Chen T.W.-W; Hsu C.-H; Yen Y.-H; Yang J.C.-H; Cheng A.-L; Sasaki S.-I; Chiu L.Y; Sugihara M; Ishizuka T; Oguma T; Tajima N; Chia-Chi Lin
臺大學術典藏 2020-05-25T07:35:00Z Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours Bogenrieder T; Twelves C; Cheng A.-L.; Huang D.C.-L; Strelkowa N; Goeldner R.-G; Schmid U; Fuertig R; Buschke S; Jove M; Anthoney A; Yen C.-J; de Bono J; Chia-Chi Lin; Chen L.-T; Corral J; Michalarea V; Rihawi K; Ong M; Lee J.-H; Hsu C.-H; Yang J.C.-H; Shiah H.-S
臺大學術典藏 2020-05-25T06:52:11Z A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil Hsu C; Yang C.-H; YEN-SHEN LU; Lin C.-C; Bu C.-F; Yeh K.-H.; Yeh K.-H.;Bu C.-F;Lin C.-C;Yen-Shen Lu;Yang C.-H;Hsu C;Cheng A.-L;Hsu C.-H; Hsu C.-H; Cheng A.-L

顯示項目 796-820 / 1656 (共67頁)
<< < 27 28 29 30 31 32 33 34 35 36 > >>
每頁顯示[10|25|50]項目